| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |